{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:00:17Z","timestamp":1790197217479,"version":"4.1.0"},"reference-count":6,"publisher":"American Society of Clinical Oncology (ASCO)","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["J Clin Oncol"],"DOI":"10.1200\/jco-26-01873","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:59:19Z","timestamp":1790193559000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Reply to: \u201cCreatinine Assay Methods and Carboplatin Dosing Transparency in the neoCARHP Trial\u201d"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5201-2626","authenticated-orcid":false,"given":"Hong-Fei","family":"Gao","sequence":"first","affiliation":[{"name":"Hong-Fei Gao, MD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Wei Li, MD, Department\u2000of\u2000Breast\u2000Surgery,\u2000The\u2000First\u2000People\u2019s\u2000Hospital\u2000of\u2000Foshan, Foshan,\u2000China; Jie Dong, MM, Department of Breast Surgery, Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China; Ying Lin, MD, PhD, Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and Kun Wang, MD, PhD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Hong-Fei Gao, MD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Wei Li, MD, Department\u2000of\u2000Breast\u2000Surgery,\u2000The\u2000First\u2000People\u2019s\u2000Hospital\u2000of\u2000Foshan, Foshan,\u2000China; Jie Dong, MM, Department of Breast Surgery, Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China; Ying Lin, MD, PhD, Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and Kun Wang, MD, PhD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[{"name":"Hong-Fei Gao, MD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Wei Li, MD, Department\u2000of\u2000Breast\u2000Surgery,\u2000The\u2000First\u2000People\u2019s\u2000Hospital\u2000of\u2000Foshan, Foshan,\u2000China; Jie Dong, MM, Department of Breast Surgery, Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China; Ying Lin, MD, PhD, Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and Kun Wang, MD, PhD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-3306","authenticated-orcid":false,"given":"Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Hong-Fei Gao, MD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Wei Li, MD, Department\u2000of\u2000Breast\u2000Surgery,\u2000The\u2000First\u2000People\u2019s\u2000Hospital\u2000of\u2000Foshan, Foshan,\u2000China; Jie Dong, MM, Department of Breast Surgery, Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China; Ying Lin, MD, PhD, Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and Kun Wang, MD, PhD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-7080","authenticated-orcid":false,"given":"Kun","family":"Wang","sequence":"additional","affiliation":[{"name":"Hong-Fei Gao, MD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Wei Li, MD, Department\u2000of\u2000Breast\u2000Surgery,\u2000The\u2000First\u2000People\u2019s\u2000Hospital\u2000of\u2000Foshan, Foshan,\u2000China; Jie Dong, MM, Department of Breast Surgery, Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China; Ying Lin, MD, PhD, Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and Kun Wang, MD, PhD, Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"e_1_3_3_2_2","article-title":"Creatinine assay methods and carboplatin dosing transparency in the neoCARHP trial","author":"Ando Y","unstructured":"Ando Y, Shimokata T: Creatinine assay methods and carboplatin dosing transparency in the neoCARHP trial. J Clin Oncol 10.1200\/JCO-26-00381","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_3_2","unstructured":"National Health Commission of the People\u2019s Republic of China: WS\/T 413-2024: Reference measurement procedure for serum creatinine\u2014Isotope dilution liquid chromatography\u2013tandem mass spectrometry (replacing WS\/T 413-2013). 2024. Chinese. https:\/\/www.nhc.gov.cn\/wjw\/s9492\/202407\/7b69929bf00142aeb99de7b4167b0381.shtml"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1748"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_3_6_2","unstructured":"US Food and Drug Administration: Carboplatin dosing. 2010. https:\/\/web.archive.org\/web\/20111124180407\/http:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDER\/ucm228974.htm"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-02176"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-26-01873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:59:20Z","timestamp":1790193560000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO-26-01873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":6,"alternative-id":["10.1200\/JCO-26-01873"],"URL":"https:\/\/doi.org\/10.1200\/jco-26-01873","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"2026-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"JCO-26-01873"}}